Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

tebipenem

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Tebipenem pivoxil HBr (TBPM-PI-HBr) is a novel orally bioavailable carbapenem. The active moiety is tebipenem. Tebipenem pivoxil… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
2017
2017
BackgroundThe carbapenem subclass of β-lactams is among the most potent antibiotics available today. Emerging evidence shows that… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
2017
2017
AIM The objective of this study was to assess if avibactam, a new β-lactamase inhibitor, can restore the potency of carbapenems… Expand
2017
2017
BackgroundDifficult-to-treat infections caused by rapidly growing mycobacteria (RGM) are increasingly observed in clinical… Expand
  • table 1
  • table 2
2017
2017
Aim: Mycobacterium avium infections, especially in immune-compromised individuals, present a significant challenge as therapeutic… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
2016
2016
Abstract The aim of this study was to determine the kinetic and thermodynamic parameters of tebipenem degradation in the solid… Expand
2014
2014
ABSTRACT We evaluated the antituberculosis (anti-TB) activity of five β-lactams alone or in combination with β-lactamase… Expand
  • table 1
  • table 2
  • table 3
2012
2012
A inexpensive and rapid isocratic LC method has been developed for the quantitative determination of tebipenem—a new β-lactam… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
2010
2010
ABSTRACT In vitro activity of tebipenem, a new oral carbapenem antibiotic, against clinical Haemophilus influenzae isolates was… Expand
  • table 1
  • figure 1
  • table 2
  • figure 2
2005
2005
ABSTRACT The in vitro activity of tebipenem (TBM), a new oral carbapenem antibiotic, against Streptococcus pneumoniae clinical… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3